Mohan Pankaj 4
4 · Sonnet BioTherapeutics Holdings, Inc. · Filed Dec 22, 2022
Insider Transaction Report
Form 4
Mohan Pankaj
DirectorChairman, President and CEO
Transactions
- Award
Common Stock
2022-12-14+74,205→ 748,606 total
Holdings
- 7,992(indirect: By Children)
Common Stock
- 930,705(indirect: By Mohan Family Office)
Common Stock
Footnotes (3)
- [F1]On December 14, 2022, the Reporting Person was granted 74,205 restricted stock units, which will be settled in shares of common stock, par value $0.0001. The restricted stock units vest as to 100% of the restricted stock units on January 1, 2024.
- [F2]Includes unvested RSUs.
- [F3]Reporting Person jointly exercises dispositive and voting power over the securities owned by the Mohan Family Office.